EPISODE · Jul 3, 2026 · 7 MIN
Most common symptoms and immunity
from Dr. John Campbell · host Campbellteaching
Runny nose, 76%. Headache, 75% Sneezing, 66% Sore throat, 52% Loss of smell, 52% https://covid.joinzoe.com/blog https://www.youtube.com/watch?v=xoGqyFUoUSw Most common symptoms in vaccinated and children Runny nose, 76% Headache, 75% Sneezing, 66% Sore throat, 52% Loss of smell, 52% (Fever nor chronic cough in the top symptoms) Out of date government advice misses 40% of infections Natural immunity, levels of protection against reinfection Natural infection alone in past year, 65% 2 doses of AZ in past 6 months, 71% 2 doses of Pfizer in past 6 months, 83% Infection (past year) followed by 2 doses of AZ, 90% Infection (past year) followed by 2 doses of Pfizer, 94% Contradicts Israeli data Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1.full.pdf Protection from prior SARS-CoV-2 infection, 94·8% Hospitalization 94·1% Severe illness 96·4% Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Runny nose, 76%. Headache, 75% Sneezing, 66% Sore throat, 52% Loss of smell, 52% https://covid.joinzoe.com/blog https://www.youtube.com/watch?v=xoGqyFUoUSw Most common symptoms in vaccinated and children Runny nose, 76% Headache, 75% Sneezing, 66% Sore throat, 52% Loss of smell, 52% (Fever nor chronic cough in the top symptoms) Out of date government advice misses 40% of infections Natural immunity, levels of protection against reinfection Natural infection alone in past year, 65% 2 doses of AZ in past 6 months, 71% 2 doses of Pfizer in past 6 months, 83% Infection (past year) followed by 2 doses of AZ, 90% Infection (past year) followed by 2 doses of Pfizer, 94% Contradicts Israeli data Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1.full.pdf Protection from prior SARS-CoV-2 infection, 94·8% Hospitalization 94·1% Severe illness 96·4% Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Most common symptoms and immunity
No transcript for this episode yet
Similar Episodes
Jun 30, 2026 ·98m
Jun 23, 2026 ·35m
Jun 16, 2026 ·100m
Jun 9, 2026 ·83m
May 26, 2026 ·94m